Lifeline Biotechnologies, Inc. (LLBO)

0.0005 0.0000 (0.00%) As of 01:31PM EDT. Market open.

Lifeline Biotechnologies, Inc.

1325 Airmotive Way
Suite 175
Reno, NV 89502
United States
775-852-3222
https://www.lbti.co

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. James D. Holmes CPA, MBA	Chairman, Chief Executive Officer and Treasurer	N/A	N/A	N/A
Dr. William H. Reeves Ph.D.	Founder	N/A	N/A	N/A
Dr. Louis G. Keith M.D., Ph.D.	Vice President, Medical Director, Secretary and Director	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.

Corporate Governance

Lifeline Biotechnologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.